arBtrage CAPITALIZING MARKETS checking… Sign in

AbbVie Inc.

ABBV Health Care Biotechnology: Pharmaceutical Preparations
$227.23
▲ +1.0% Today
as of Jun 7, 07:07 ET
Last 30 days +14.94% Apr 28 → Jun 05
$195.33 $203.89 $212.46 $221.03 $229.59 Apr 28 May 05 May 13 May 20 May 29 Jun 05
Open
$227.37
High
$230.47
Low
$226.00
Volume
$5M
Avg Vol
$6M
Mkt Cap
$386.3B
P/E (TTM)
224.98
Beta
52w High
$244.81
52w Low
$181.73
Div Yield
Shares Out

Overview

52-week range
$182
$245
72% of range
Avg surprise (last 1)
+2.9%
Avg reaction (last 1)
+3.2%
100% positive
Latest IV / EM
32%
EM ±3.0% · $228 · Jun 12

Earnings trends

EPS — actual vs estimate Actual Estimate
$0.10$0.69$1.28$1.87$2.46 Actual $1.14Actual $1.00Actual $0.77Actual $0.77Actual $0.88Actual $2.46Est $2.39Actual $0.52Actual $0.10Actual $0.39 JunSepMarJunSepMar/2025JunSepMar
Revenue vs Net Income Revenue Net income
$0$4.1B$8.3B$12.4B$16.6B Jun 24Sep 24Mar 25Jun 25Sep 25Mar 26

Earnings history

DatePeriodActual EPSEstSurpriseYoY %ΔDay reactSource
Tue Mar 31, 2026Mar 2026 $0.39 financials
Tue Sep 30, 2025Sep 2025 $0.10 financials
Mon Jun 30, 2025Jun 2025 $0.52 financials
Fri Apr 25, 2025Mar/2025 $2.46 $2.39 +2.9% +3.2% earnings
Mon Sep 30, 2024Sep 2024 $0.88 financials
Sun Jun 30, 2024Jun 2024 $0.77 financials
Sun Mar 31, 2024Mar 2024 $0.77 financials
Sat Sep 30, 2023Sep 2023 $1.00 financials
Fri Jun 30, 2023Jun 2023 $1.14 financials

Financials

Income statement (quarterly)

MetricMar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024
Revenue$15.00B$15.78B$15.42B$13.34B$14.46B$14.46B
Cost of revenue$4.22B$5.30B$4.35B$4.00B$4.21B$4.20B
Gross profit
Operating income$3.99B$1.90B$4.89B$3.73B$3.83B$4.00B
Net income$695M$186M$938M$1.29B$1.56B$1.37B
EPS (diluted)$0.39$0.10$0.52$0.72$0.88$0.77

Balance sheet (quarterly)

MetricMar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024
Cash & equivalents$9.39B$5.23B$5.63B$6.47B$5.17B$5.52B$7.26B$13.13B
Inventory$5.05B$4.95B$4.94B$4.96B$4.53B$4.18B$4.45B$4.22B
Total current assets$33.53B$29.06B$28.54B$29.26B$27.68B$25.58B$27.79B$33.82B
Total assets$136.46B$133.96B$133.90B$137.18B$136.16B$135.16B$143.42B$141.94B
Long-term debt
Total liabilities
Total equity$-6.66B$-3.27B$-2.64B$-183M$1.42B$3.33B$6.03B$6.78B

Implied volatility — last 90 days

27%29%32%34%37% Jun 07 — IV 32% · EM ±3.0%

Sector peers